Agenus (AGEN) awards 200,000 stock options to executive chair Jennifer Buell
Rhea-AI Filing Summary
Agenus Inc. reported that director and officer Jennifer Buell received a grant of stock options covering 200,000 shares of common stock at an exercise price of $7.78 per share. The options, expiring on August 5, 2036, were awarded under the 2019 Amended and Restated Equity Incentive Plan and vest over three years, with one-third after the first anniversary of the grant date and the remaining two-thirds in two equal annual installments. Following this grant, Buell holds 200,000 stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Buell Jennifer
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 200,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 200,000 shares (Direct)
Footnotes (1)
- F1. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.
Key Figures
Options Granted: 200,000 shares
Exercise Price: $7.78 per share
Expiration Date: August 5, 2036
+3 more
6 metrics
Options Granted
200,000 shares
Stock options on common stock granted to Jennifer Buell
Exercise Price
$7.78 per share
Exercise price of the newly granted stock options
Expiration Date
August 5, 2036
Option term for the granted stock options
Post-Grant Option Holdings
200,000 options
Total options held directly by Jennifer Buell after the grant
Initial Vesting Portion
1/3 of options
Vests on the first anniversary of the grant date
Remaining Vesting Portion
2/3 of options
Vests in two equal annual installments after the first anniversary
Key Terms
2019 Amended and Restated Equity Incentive Plan, exercise price, vesting, Grant Date
4 terms
2019 Amended and Restated Equity Incentive Plan financial
"Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan"
exercise price financial
"stock options covering 200,000 shares at an exercise price of $7.78 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"options vest over three years, with one-third after the first anniversary and the rest in installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Grant Date financial
"one-third vesting on the first anniversary of the Grant Date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did insider Jennifer Buell receive in this AGEN Form 4 filing?
Jennifer Buell received a grant of 200,000 stock options on Agenus Inc. common stock. These options were awarded under the company’s 2019 Amended and Restated Equity Incentive Plan as part of her role as a director and officer.
What is the exercise price of the options granted to Jennifer Buell at AGEN?
The options granted to Jennifer Buell have an exercise price of $7.78 per share. This is the price she would pay per share to convert the options into Agenus Inc. common stock, subject to vesting and other plan terms.
How do the AGEN stock options granted to Jennifer Buell vest over time?
The 200,000 options vest over three years: one-third on the first anniversary of the grant date, and the remaining two-thirds in two equal annual installments thereafter, consistent with the company’s equity incentive plan.
When do Jennifer Buell’s newly granted AGEN stock options expire?
The stock options granted to Jennifer Buell expire on August 5, 2036. After this expiration date, any unexercised options will lapse and can no longer be exercised for Agenus Inc. common shares.
How many Agenus (AGEN) stock options does Jennifer Buell hold after this grant?
After this grant, Jennifer Buell holds 200,000 stock options directly. This reflects the full amount of the newly awarded options reported, as no prior option holdings are listed in this insider transaction summary.